HDAC9 and asthma: Research has shown that HDAC inhibitors can attenuate airway inflammation and improve lung function in animal models of asthma, with particularly encouraging results seen in T2-low and non-T2 asthma phenotypes, which are often less responsive to conventional corticosteroid therapies [145].